Vivani Medical Announces Merger of Cortigent Into ClearOne Subsidiary

What Happened

• Vivani Medical, Inc. filed a Regulation FD disclosure on September 16, 2026 confirming a previously announced definitive agreement and plan of merger. Under the agreement, Vivani’s wholly owned subsidiary Cortigent, Inc. will merge with and into CLRO Merger Sub, Inc. (MergerSub) and become a wholly owned subsidiary of ClearOne, Inc. Vivani anticipates pricing and closing of the transaction will occur in October 2026.

Key Details

• Filing type: Form 8-K (Item 7.01, Regulation FD Disclosure) filed Sept 16, 2026.
• Parties: Vivani Medical, Inc.; Cortigent, Inc. (Vivani subsidiary); ClearOne, Inc.; CLRO Merger Sub, Inc.
• Transaction: Cortigent will merge into MergerSub and become a ClearOne wholly owned subsidiary.
• Timing: Pricing and closing expected in October 2026.

Why It Matters

• This confirms a definitive corporate transaction that will move ownership of Cortigent from Vivani to ClearOne on closing. Investors should note the expected October 2026 timing; any financial or strategic impact to Vivani will depend on the final pricing and the closing mechanics disclosed in future filings.